Eisai Co., Ltd. and Nuvation Bio Inc. (NYSE: NUVB) announced that the European Medicines Agency has validated their Marketing Authorisation ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE